Por favor, inténtelo con una nueva búsqueda
Nombre | Edad | Desde | Título |
---|---|---|---|
Thomas G. Ricks | 70 | 2015 | Independent Director |
William R. Ringo | 78 | 2022 | Independent Chairman |
John K. Celebi | 51 | 2018 | President, CEO & Director |
Robert Holmen | 59 | 2017 | Independent Director |
Alain Algazi | - | - | Member of Immuno-Oncology Advisory Board |
Kristian Humer | 49 | 2021 | Independent Director |
Richard J. Ulevitch | 80 | 2021 | Member of Immuno-Oncology Advisory Board |
Maura Gillison | - | 2021 | Member of Immuno-Oncology Advisory Board |
James Peyer | 37 | 2020 | Independent Director |
Sara Pai | - | - | Member of Immuno-Oncology Advisory Board |
Deneen Vojta | 59 | 2021 | Independent Director |
Jessie M. English | 60 | 2021 | Independent Director |
Robert Schreiber | - | - | Member of Immuno-Oncology Advisory Board |
Daniel H. Sterman | - | - | Member of Immuno-Oncology Advisory Board |
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Díganos qué piensa de este comentario
Gracias
Su denuncia será examinada por nuestros moderadores